NYMXF · Nymox Pharmaceutical Corp
Market Cap
$21,008
Shares
105.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-31 | — | |
| 6-K | 2026-08-07 | — | |
| 6-K | 2026-06-03 | 2026-06-02 | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2025-11-07 | — | |
| 6-K | 2025-10-22 | — | |
| 6-K | 2025-10-22 | — | |
| 6-K | 2025-09-23 | — | |
| 20-F | 2025-06-03 | 2024-12-31 | |
| 6-K | 2025-05-22 | — | |
| 6-K | 2025-03-11 | — | |
| 6-K | 2025-01-02 | 2024-09-30 | |
| 6-K | 2024-12-17 | — | |
| 20-F | 2024-08-29 | 2023-12-31 | |
| 6-K | 2024-07-18 | — | |
| 6-K | 2024-07-16 | 2024-07-17 | |
| 6-K | 2024-05-13 | — | |
| 6-K | 2024-03-28 | — | |
| 6-K | 2023-11-15 | 2023-09-30 | |
| 6-K | 2023-11-09 | — | |
| 6-K | 2023-11-06 | 2023-11-03 | |
| 6-K | 2023-10-26 | — | |
| 6-K | 2023-09-25 | — | |
| 6-K | 2023-08-29 | — | |
| 6-K | 2023-08-14 | 2023-06-30 | |
| 6-K | 2023-08-02 | — | |
| 6-K | 2023-07-31 | — | |
| 6-K | 2023-07-25 | — | |
| 6-K | 2023-07-25 | — | |
| 6-K | 2023-07-12 | — | |
| 6-K | 2023-07-06 | 2023-07-05 | |
| 6-K | 2023-06-29 | — | |
| 6-K/A | 2023-06-29 | 2023-06-28 | |
| 6-K | 2023-06-27 | — | |
| 6-K | 2023-05-12 | 2023-03-31 | |
| 20-F | 2023-05-02 | 2022-12-31 | |
| 6-K | 2023-01-06 | 2023-01-04 | |
| 6-K/A | 2022-11-16 | 2022-11-10 | |
| 6-K/A | 2022-11-16 | 2022-09-30 | |
| 6-K | 2022-11-14 | 2022-11-10 | |
| 6-K | 2022-11-14 | 2022-09-30 | |
| 6-K | 2022-08-15 | 2022-06-30 | |
| 6-K | 2022-07-08 | 2022-06-28 | |
| 6-K | 2022-05-13 | 2022-03-31 | |
| 20-F | 2022-03-30 | 2021-12-31 | |
| 6-K | 2022-03-22 | — | |
| 6-K/A | 2021-11-22 | 2021-11-19 | |
| 6-K | 2021-11-19 | — | |
| 6-K | 2021-11-12 | 2021-09-30 | |
| 6-K | 2021-08-13 | 2021-06-30 |
Showing 1–50 of 66 filings